Vyndamax (tafamidis) is a life-changing medication for transthyretin amyloid cardiomyopathy (ATTR-CM), a progressive and often fatal heart condition. Approved by the FDA in 2019, Vyndamax slows disease progression and reduces cardiovascular hospitalizations. But its list price has made affordability a major concern. In 2026, how much does Vyndamax cost for Americans? The answer depends on your insurance, pharmacy, and whether you qualify for Pfizer’s assistance programs. Let’s dive into current pricing, coverage options, and actionable ways to lower your expense.
What Is Vyndamax and Why Is It Expensive?
Vyndamax (61 mg capsules, taken once daily) is a specialty drug that stabilizes the transthyretin protein, preventing it from forming amyloid deposits in the heart. Because it treats a rare disease (orphan drug status), Pfizer set a high annual list price. Without any assistance, the wholesale acquisition cost (WAC) for Vyndamax exceeds $250,000 per year. However, few patients pay that full amount thanks to insurance and copay programs.
Vyndamax Cost Breakdown: 2026 Table
| Scenario | Monthly Cost (30-day supply) | Annual Cost Estimate |
|---|---|---|
| List price (no insurance, no assistance) | $21,000 – $23,000 | $252,000 – $276,000 |
| Commercial insurance (typical out-of-pocket) | $250 – $1,500* | $3,000 – $18,000 |
| Medicare Part D (standard coverage, 2026) | $750 – $2,000* | $9,000 – $24,000 |
| Medicare with Extra Help / Low-income subsidy | $0 – $100 | $0 – $1,200 |
| Pfizer Vyndamax Copay Program (commercially insured) | $0 – $25 | $0 – $300 |
| Pfizer Bridge Program (uninsured / underinsured) | $0 | $0 |
*Deductibles, coinsurance, and plan tiers cause wide variation. Always verify with your insurer.
Insurance and Medicare: What You’ll Really Pay in 2026
Commercial Health Plans (Employer/ACA)
Most private insurers place Vyndamax on specialty tier (Tier 4 or 5). Your cost depends on deductible and coinsurance (typically 20-33% after deductible). For 2026, many plans have capped out-of-pocket maximums ($8,000–$9,000 individual). That means the most you might pay annually is your plan’s OOP max — but you can leverage the Pfizer copay assistance to reduce that to near zero.
Medicare Part D (2026 Updates)
Vyndamax is covered under most Medicare Part D plans, but it's not on every formulary. The Inflation Reduction Act continues to cap insulin at $35/month, but for Vyndamax, you may face high coinsurance in the catastrophic phase. In 2026, the out-of-pocket spending cap for Part D is $2,000 (thanks to IRA implementation). That means once you spend $2,000 on covered drugs, you pay nothing for the rest of the year — a huge relief for Vyndamax patients. However, this applies only to Medicare Part D, not commercial plans. Always confirm your plan’s coverage.
How to Reduce Your Vyndamax Cost: A 5-Step Checklist
- Step 1: Enroll in the Pfizer Vyndamax Copay Program – available to commercially insured patients. Visit VyndamaxPro.com or call 1-877-820-7789.
- Step 2: If you have Medicare, apply for the Part D Low-Income Subsidy (Extra Help) – it can reduce your monthly cost to $0–$4.50.
- Step 3: Compare Medicare Part D plans during open enrollment (Oct 15 – Dec 7) to find one that includes Vyndamax on formulary with preferred specialty tier.
- Step 4: Use a specialty pharmacy that partners with Pfizer’s patient assistance; they often handle prior authorization and copay cards automatically.
- Step 5: For uninsured or denied coverage, apply to the Pfizer Bridge Program (income-based, but flexible for medical need).
Vyndamax vs. Vyndaqel: Cost Differences
Vyndaqel (20 mg capsules) is an alternative formulation for ATTR-CM but requires 4 capsules daily (80 mg total). Vyndamax offers once-daily 61 mg dosing (bioequivalent to 80 mg of Vyndaqel). From a cost perspective, the list price per month is similar, but insurance coverage may differ. Most plans prefer Vyndamax due to convenience. If your plan doesn’t cover Vyndamax, ask your doctor about a formulary exception.
Real Patient Scenarios: How Much Does Vyndamax Cost in the US in 2026?
- Case 1 – Maria (Texas, employer PPO): Deductible $3,000, coinsurance 20%. Maria’s first fill cost $3,000 (deductible). Then 20% of $21,000 = $4,200. But she used Pfizer copay card which covered all but $25 per month. Total annual out-of-pocket: $300.
- Case 2 – James (Florida, Medicare Part D): Plan with $545 deductible, then 25% coinsurance. Vyndamax monthly cost ~$5,000 until catastrophic. Under IRA, after $2,000 true OOP, no more costs. James paid around $2,000 total for the year.
- Case 3 – Linda (uninsured, Ohio): Approved for Bridge Program – receives Vyndamax at no cost after providing medical records and income verification (under 500% FPL).
Other Financial Resources & Manufacturer Assistance
Beyond Pfizer’s own programs, non-profits like the HealthWell Foundation and PAN Foundation offer copay grants for ATTR-CM. In 2026, HealthWell has a specific fund for Vyndamax with up to $15,000 per year. Also check with the Amyloidosis Foundation for travel and medication grants.